ANDA 87760, held by Ivax Sub Teva Pharms. Hydroxyzine Pamoate.
As of Nov 15, 2026, ANDA 87760 (Hydroxyzine Pamoate), held by Ivax Sub Teva Pharms, was first approved by FDA on Mar 5, 1982, with 19 approved supplements and 0 published complete response letters.
| Date | Submission | Status | Documents |
|---|---|---|---|
| Mar 5, 1982 | Original application | Approved | None posted |
| Product | Active ingredient | Marketing |
|---|---|---|
| Hydroxyzine PamoateEQ 50MG HYDROCHLORIDE ยท capsule;oral | Hydroxyzine Pamoate | Discontinued |
| Jul 29, 2002 | Supplement 21Manufacturing | Approved | None posted |
| Sep 12, 2001 | Supplement 20Manufacturing | Approved | None posted |
| Nov 13, 2000 | Supplement 19Manufacturing | Approved | None posted |
| Jul 5, 2000 | Supplement 18Labeling | Approved | None posted |
| Jul 5, 2000 | Supplement 16Manufacturing | Approved | None posted |
| Jan 28, 2000 | Supplement 17Manufacturing | Approved | None posted |
| Apr 30, 1999 | Supplement 15Manufacturing | Approved | None posted |
| Apr 30, 1999 | Supplement 14Manufacturing | Approved | None posted |
| Apr 30, 1999 | Supplement 13Manufacturing | Approved | None posted |
| Dec 9, 1998 | Supplement 12Manufacturing | Approved | None posted |
| May 30, 1997 | Supplement 11Manufacturing | Approved | None posted |
| Oct 26, 1992 | Supplement 7Manufacturing | Approved | None posted |
| Oct 16, 1992 | Supplement 10Labeling | Approved | None posted |
| Sep 1, 1992 | Supplement 6Manufacturing | Approved | None posted |
| Aug 25, 1989 | Supplement 1Labeling | Approved | None posted |
| Feb 11, 1988 | Supplement 5Manufacturing | Approved | None posted |
| Sep 15, 1987 | Supplement 4Manufacturing | Approved | None posted |
| Sep 15, 1987 | Supplement 3Manufacturing | Approved | None posted |
| Sep 15, 1987 | Supplement 2Manufacturing | Approved | None posted |
| Mar 5, 1982 | Original application | Approved | None posted |
Approvals, supplements, products and documents come from FDA's Drugs@FDA data files, refreshed daily; Drugs@FDA lists approved applications only. Complete response letters are FDA's published letters. Drugs@FDA and FDA complete response letters